Der er rapporteret alvorlige, og ind i mellem fatale, overfølsomhedsreaktioner (anafylaktiske reaktioner) hos patienter i behandling med beta- lactamer.
Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams.